Thursday, November 5, 2026 Login
Neuroplasticity News
News, research and plain-language guides on brain change and recovery
Neuroplasticity News — Brain recovery, research and rehabilitation. READ THE NEWS
Constraint-Induced Movement Therapy: More Than Wearing a Mitt

Constraint-Induced Movement Therapy: More Than Wearing a Mitt

Written by Neuroplasticity News Editorial TeamOctober 29, 2026Stroke Recovery1 min read

The mitt is not the whole treatment

Pictures often show a restraint on the less-affected hand, but constraint-induced movement therapy is a package of selected arm practice and behavioral support. After stroke, using the affected arm may be slow or frustrating. Reliance on the stronger arm is understandable. Learned nonuse describes one pattern, but weakness, sensory loss, pain and coordination difficulties are real impairments, not a lack of effort.

What a program includes

Treatment commonly combines repetitive task-specific training, progressive task shaping and methods that encourage everyday use. Selected patients wear a restraint for prescribed periods. Modified programs use different schedules. Eligibility requires assessment of active movement, pain, cognition, sensation and practical safety. Someone who needs the stronger hand for transfers, balance or mobility should not improvise a restraint program at home.

What EXCITE showed

The 2006 EXCITE randomized trial studied people three to nine months after a first stroke who retained some hand and wrist movement. The intervention improved measured arm performance and reported everyday use compared with usual care. This supports the treatment in selected patients, not universal suitability. Varying usual care means the trial cannot isolate the mitt from intensive practice and behavioral support.

Choosing meaningful goals

Ask whether your current movement makes you a candidate, what components a service offers and how progress is measured. Practical goals might include stabilizing a bowl or handling clothing. Separate timing research in the 2021 CPASS trial shows why recovery stage deserves attention. Neither study supplies a single prescription for everyone. Other arm rehabilitation methods remain appropriate when this treatment is unsuitable; needing an alternative does not mean recovery potential has disappeared.

This evidence supports informed conversations, not an individualized prediction. Study populations and comparison conditions matter when considering how findings apply to a particular person. Bring your priorities and questions to a qualified professional who can assess your circumstances.

Sources

This article is for general information, not individual medical advice. Illustration is AI-generated and does not depict actual study participants.

Frequently Asked Questions

What does the evidence support?
The 2006 EXCITE randomized trial studied people three to nine months after a first stroke who retained some hand and wrist movement. The intervention improved measured arm performance and reported everyday use compared with usual care. This supports the treatment in selected patients, not universal suitability. Varying usual care means the trial cannot isolate the mitt from intensive practice and behavioral support.
How should I interpret the findings?
Consider the population, comparison treatment and outcomes studied. Findings do not guarantee the same result for an individual.
What should I discuss with my clinician?
Ask how this evidence fits your goals, current abilities, safety needs and existing treatment plan.
Share:

Written by

Neuroplasticity News Editorial Team

The Neuroplasticity News editorial team covers brain science, rehabilitation research and clinical trials, translating peer-reviewed evidence into clear, accurate reporting for patients, families and professionals.

Related Posts

Subscribe to news updates